Send to

Choose Destination
See comment in PubMed Commons below
Br J Neurosurg. 2008 Jun;22(3):452-5. doi: 10.1080/02688690802182256.

'Recurrent' glioblastoma multiforme, when should we reoperate?

Author information

  • 1Department of Neurosurgery, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerly, Liverpool, UK.


The surgical management of recurrent glioblastoma multiforme is controversial. Recent publications suggest that re-operation provides 3-5 months median survival, without significant increases in morbidity or mortality. Age (< or =50 years, although older patients may also benefit) and performance status (Karnofsky performance score > or =60-70) are the most important factors. Re-resection not only improves symptoms and maintains quality of life, it can delay symptom progression, reduce corticosteroid doses, and also improve response to (and allow intra-operative) chemotherapy and/or radiotherapy. Surgical treatment of recurrent glioblastoma multiforme in selected patients should always be considered.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center